243 related articles for article (PubMed ID: 27717499)
1. [Pediatric ependymomas: Current diagnosis and therapy].
Frappaz D; Vasiljevic A; Beuriat PA; Alapetite C; Grill J; Szathmari A; Faure-Conter C
Bull Cancer; 2016 Oct; 103(10):869-879. PubMed ID: 27717499
[TBL] [Abstract][Full Text] [Related]
2. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
3. Intracranial ependymomas of childhood: current management strategies.
Smyth MD; Horn BN; Russo C; Berger MS
Pediatr Neurosurg; 2000 Sep; 33(3):138-50. PubMed ID: 11096361
[TBL] [Abstract][Full Text] [Related]
4. Advances in Management of Pediatric Ependymomas.
Lin FY; Chintagumpala M
Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
[TBL] [Abstract][Full Text] [Related]
5. Clinical aspects and prognosis of ependymoma in infants and children. A single institution experience.
Humpl T; Neuser H; Brühl K; Bartels U; Schwarz M; Gutjahr P
Childs Nerv Syst; 2001 Apr; 17(4-5):246-51. PubMed ID: 11398944
[TBL] [Abstract][Full Text] [Related]
6. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
Dorfer C; Tonn J; Rutka JT
Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
8. Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Venkatramani R; Ji L; Lasky J; Haley K; Judkins A; Zhou S; Sposto R; Olshefski R; Garvin J; Tekautz T; Kennedy G; Rassekh SR; Moore T; Gardner S; Allen J; Shore R; Moertel C; Atlas M; Dhall G; Finlay J
J Neurooncol; 2013 Jun; 113(2):285-91. PubMed ID: 23508296
[TBL] [Abstract][Full Text] [Related]
9. Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.
Messahel B; Ashley S; Saran F; Ellison D; Ironside J; Phipps K; Cox T; Chong WK; Robinson K; Picton S; Pinkerton CR; Mallucci C; Macarthur D; Jaspan T; Michalski A; Grundy RG;
Eur J Cancer; 2009 Jul; 45(10):1815-23. PubMed ID: 19427780
[TBL] [Abstract][Full Text] [Related]
10. Intracranial ependymoma: factors affecting outcome.
Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
[TBL] [Abstract][Full Text] [Related]
11. [Intracranial ependymomas. Experience with 86 cases].
Lejeune JP; Dhellemmes P; Dupard T; Combelles G; Delandsheer JM
Neurochirurgie; 1987; 33(2):118-23. PubMed ID: 3600940
[TBL] [Abstract][Full Text] [Related]
12. Ependymoma: Evaluation and Management Updates.
Rudà R; Bruno F; Pellerino A; Soffietti R
Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
[TBL] [Abstract][Full Text] [Related]
13. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
14. Ependymoma: an update.
Zacharoulis S; Moreno L
J Child Neurol; 2009 Nov; 24(11):1431-8. PubMed ID: 19841430
[TBL] [Abstract][Full Text] [Related]
15. [Interdisciplinary therapy of childhood ependymomas].
Timmermann B; Kortmann RD; Kühl J; Willich N; Bamberg M
Strahlenther Onkol; 2002 Sep; 178(9):469-79. PubMed ID: 12426832
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
17. Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors.
Goldwein JW; Glauser TA; Packer RJ; Finlay JL; Sutton LN; Curran WJ; Laehy JM; Rorke LB; Schut L; D'Angio GJ
Cancer; 1990 Aug; 66(3):557-63. PubMed ID: 2364367
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in patients harboring intracranial ependymoma.
Kawabata Y; Takahashi JA; Arakawa Y; Hashimoto N
J Neurosurg; 2005 Jul; 103(1):31-7. PubMed ID: 16121970
[TBL] [Abstract][Full Text] [Related]
19. An overview of the management of adult ependymomas with emphasis on relapsed disease.
Iqbal MS; Lewis J
Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):726-33. PubMed ID: 23972764
[TBL] [Abstract][Full Text] [Related]
20. Brain tumors: Medulloblastoma, ATRT, ependymoma.
Baliga S; Gandola L; Timmermann B; Gail H; Padovani L; Janssens GO; Yock TI
Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28395. PubMed ID: 32386126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
